In response to the concurrent epidemics of COVID-19 and opioid-related harm, federal and state agencies have taken steps to temporarily remove some legal and regulatory barriers to treatment for opioid use disorder (OUD). These changes have the potential to improve access to lifesaving medications for OUD (MOUD), particularly among those most at risk. However, they are set to expire with the COVID-19 public health emergency declaration. This webinar will describe these legal and regulatory modifications, how they are being used to increase access to OUD treatment, and opportunities to permanently increase access to MOUD.
This webinar will provide you with: